CCL2 induces the recruitment of ILC3s to tumors and stimulates the production of CXCL13 by tumor stromal cells, which ultimately leads to the production of the cancer cell motility factor receptor activator of NF-κB ligand and promotes lymphatic metastasis of breast cancer cells 118. This evidence concerns the gene CCL2 and cancer.